Found 0 matching trials
Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck PHASE1 This is a phase 1 study of the drug dacomitinib with radiotherapy, with or ...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder PHASE1 The purpose of this study is to investigate the safety and efficacy of intr...
Show More Location
Multiple Locations
Learn More & Join Trial
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients PHASE3 This is a multicenter, randomized controlled, phase III clinical trial. The...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer PHASE2 This trial is designed to test the efficacy of fluoxetine to improve patien...
Show More Location
Northeast Alabama Regional Medical Center
Learn More & Join Trial
Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer PHASE3 This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Show More Location
The Second Hospital of Anhui Medical University
Learn More & Join Trial
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer PHASE1 RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally a...
Show More Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N PHASE2 The main objective of this research is to increase the life expectancy of p...
Show More Location
Institut de Cancérologie de Lorraine
Learn More & Join Trial
RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer PHASE1 RAD001 is approved by the U.S Food and Drug Administration (FDA) to treat a...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease PHASE2 This study is intended to evaluate the ability of SENS-401 to prevent the o...
Show More Location
Hôpital Henri Mondor
Learn More & Join Trial